Trials / Completed
CompletedNCT02565784
Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
An Open, Evaluator-blinded, Non-comparative, Multi-center Study to Assess the Safety and Efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine for Facial Augmentation in Asian Population
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- Female
- Age
- 25 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Restylane Lidocaine and Restylane Perlane Lidocaine after the first and second treatment when used for facial augmentation in Asian population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane | Facial tissue augmentation |
| DEVICE | Perlane | Facial tissue augmentation |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-12-29
- Completion
- 2018-09-28
- First posted
- 2015-10-01
- Last updated
- 2022-08-26
- Results posted
- 2019-10-03
Locations
2 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02565784. Inclusion in this directory is not an endorsement.